查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1918368

藻类来源的二十二碳六烯酸 (DHA) 市场 - 2026-2031 年预测

Algal Docosahexaenoic Acid (DHA) Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计藻类衍生的二十二碳六烯酸 (DHA) 市场将保持 6.9% 的复合年增长率，从 2025 年的 14.38 亿美元增长到 2031 年的 21.46 亿美元。

藻类来源的二十二碳六烯酸 (DHA) 是一种对大脑发育和功能至关重要的必需Omega-3脂肪酸，作为一种永续的素食替代品，正日益受到关注，以取代传统的鱼类来源。藻类来源的DHA由微藻类生产，不仅解决了过度捕捞和环境影响的问题，也满足了纯素和素食者的需求——由于人体自身合成DHA的能力有限，他们需要从外部摄入DHA。更广泛的DHA市场涵盖了医药、食品饮料以及其他众多领域的应用，并以油、粉末和软胶囊等形式面向个人消费者和工业终端用户。

市场成长主要受营养保健品和製药业的扩张等因素驱动。随着对高品质营养保健品的需求不断增长，藻类来源的DHA已成为关键成分，尤其是在亚太和非洲等快速成长的经济体中。以印度500亿美元的製药产业为例，製药业的蓬勃发展也促进了藻类来源的DHA在满足不断变化的医疗需求方面的应用。

消费者对DHA益处的认知不断提高，也加速了其普及。 DHA的许多好处，例如促进大脑健康、心血管功能和整体健康，以及对某些特定疾病的益处，例如预防早产、自闭症、注意力缺陷多动障碍（ADHD）、忧郁症和抗生素引起的肠道炎症，都推动了市场对DHA补充剂的需求。藻油调节肠道菌丛和代谢的能力增强了其治疗价值。监管政策的发展也支持这一趋势，证实了藻类来源的DHA在婴幼儿营养等敏感应用领域的有效性。

DHA市场按应用领域细分：在製药领域，它被广泛用于婴儿奶粉、孕期补充剂以及治疗阿兹海默症、过动症和心血管疾病的药物中。在食品饮料领域，它被用于强化牛奶、优格、鸡蛋和麵包等产品。其他应用包括作为饲料添加剂用于动物营养、用于水产养殖以促进生物健康以及用于化妆品以达到护肤功效。

受消费者日益增强的永续性和环境保护意识的推动，欧洲市场预计将占据相当大的份额。消费者对Omega-3脂肪酸有益于大脑和心臟健康的认识不断提高，加上成熟的营养保健品和製药基础设施，为强大的分销网络提供了支撑。零售药品支出的成长也进一步推动了该地区对藻类来源DHA产品的需求。

关键挑战在于价格竞争。由于藻类来源的DHA需要受控的培养环境和特殊的萃取技术，其生产成本较高，这可能会限制其与鱼油替代品相比的供应量。然而，不断增长的需求和技术的持续进步有望降低成本，使永续的植物来源产品更具经济可行性。

就市场趋势而言，Aker BioMarin 的 Lisobet™ 于 2023 年 8 月在美国获得新食品成分 (NDI)核准。该成分是一种有益大脑健康的成分，提供源自磷虾的磷脂结合 EPA/DHA，核准扩大了面向普通成年人群的销售，从而推出了旨在支持认知功能的补充剂。

公司知名产品包括Corbion的AlgaPrime™ DHA，这是一种用于动物饲料的植物性Omega-3来源，由在封闭池塘中培养的专有单细胞藻类製成。它采用高DHA含量的包封油，呈现流动性良好的粉末状，优先考虑饲料配方的永续性和可靠性。

Jedwards International 提供含有 40% DHA 的蒸馏藻油，这是一种植物来源补充剂，满足了人们对非海洋来源的Omega-3的需求，omega-3 是人类健康和福祉所必需的。

ProCaps Laboratories 的 Algal DHA 250 是一种高浓度、非基因改造藻油配方，作为一种永续的植物来源DHA 补充剂而开发，旨在满足消费者对环境友好型Omega-3产品的需求。

藻类来源的DHA领域正处于多种趋势的交汇点，包括日益增强的健康意识、永续性需求以及监管支持。作为一种用途广泛且环境友善的成分，DHA可应用于包括药品、营养补充剂和食品强化剂在内的许多领域，随着生产效率的提高和人们对其多方面益处的认识不断加深，该产品具有持续增长的潜力，尤其是在欧洲。

本报告的主要优势：

  • 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略进入市场的机会。
  • 市场驱动因素与未来趋势：探讨影响市场的动态因素和关键趋势及其对未来市场发展的影响。
  • 可操作的建议：利用这些见解，在快速变化的环境中做出策略决策，并发现新的商机和收入来源。
  • 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

企业如何使用我们的报告？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

研究范围：

  • 2021年至2025年的历史数据和2026年至2031年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区（包括国家）分類的收入和预测评估
  • 公司概况（策略、产品、财务资讯）及主要发展动态。

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

5. 藻类来源的二十二碳六烯酸 (DHA) 市场按应用领域划分

  • 介绍
  • 製药
  • 饮食
  • 其他的

6. 藻类来源的二十二碳六烯酸 (DHA) 市场按形式划分

  • 介绍
  • 油
  • 粉末
  • 软胶囊

7. 藻类来源的二十二碳六烯酸 (DHA) 市场按应用领域划分

  • 介绍
  • 对于个人
  • 工业的

8. 各地区藻类来源的二十二碳六烯酸 (DHA) 市场

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • Corbion
  • AlgiSys BioSciences Inc.
  • Bioriginal Food & Science Corp
  • ALGANEX GmbH
  • childlifenutrition.com
  • Apeiron Elementals
  • LUS Health Ingredients BV
  • Life's Code
  • ProCaps Laboratories, LLC
  • Jedwards International, Inc.

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061616414

Algal Docosahexaenoic Acid (DHA) Market, sustaining a 6.9% CAGR, is anticipated to rise from USD 1.438 billion in 2025 to USD 2.146 billion in 2031.

Algal docosahexaenoic acid (DHA), an essential omega-3 fatty acid critical for brain development and function, has emerged as a sustainable, vegetarian alternative to traditional fish-derived sources. Produced from microalgae, algal DHA addresses overfishing concerns and environmental impacts associated with marine harvesting, while catering to vegan and vegetarian consumers who require external DHA intake, as the human body synthesizes limited quantities endogenously. The broader DHA market encompasses applications in pharmaceuticals, food and beverage, and diverse other sectors, with forms including oils, powders, and soft gels, serving both individual consumers and industrial end-users.

Market growth is significantly driven by expansion in the nutraceutical and pharmaceutical industries. Rising demand for high-quality dietary supplements positions algal DHA as a key ingredient, particularly in rapidly developing economies across Asia Pacific and Africa. The pharmaceutical sector's evolution, exemplified by India's industry reaching a $50 billion valuation, underscores increasing incorporation of algal DHA to meet evolving healthcare demands.

Heightened consumer awareness of DHA's benefits further accelerates adoption. Recognition of its roles in supporting brain health, cardiovascular function, overall wellness, and specific conditions-such as preterm birth prevention, autism, ADHD, depression, and antibiotic-induced intestinal inflammation-has spurred supplement demand. Algal oil's efficacy in modulating gut microbiome and metabolome profiles enhances its therapeutic appeal. Regulatory milestones reinforce this trend, providing validation for algal DHA in sensitive applications like infant nutrition.

The DHA market exhibits segmentation by application: in pharmaceuticals, it features prominently in infant formulas, pregnancy supplements, and treatments for Alzheimer's, ADHD, and cardiovascular conditions; in food and beverage, it fortifies products including milk, yogurt, eggs, and bread. Additional uses span animal nutrition via feed incorporation, aquaculture for healthier organisms, and cosmetics for skincare benefits.

Europe is projected to command a substantial market share, fueled by consumer priorities on sustainability and environmental stewardship. Growing acknowledgment of omega-3 advantages for brain and heart health, combined with a mature nutraceutical and pharmaceutical infrastructure, supports robust distribution channels. Elevated retail pharmaceutical spending further bolsters regional demand for algal DHA products.

A primary challenge involves competitive pricing dynamics. Algal DHA production entails higher costs due to controlled cultivation environments and specialized extraction techniques, potentially limiting accessibility compared to fish oil alternatives. However, escalating demand and ongoing technological improvements are expected to drive cost reductions, enhancing economic viability for sustainable, plant-based options.

In market developments, Aker BioMarine's LYSOVETA(TM), a brain health ingredient delivering LPC-bound EPA/DHA from krill, secured new dietary ingredient (NDI) status in the United States in August 2023. This approval expands marketing authorization to the general adult population, introducing a targeted supplement for cognitive support.

Notable company offerings include Corbion's AlgaPrime(TM) DHA, a vegetarian omega-3 source for animal feed. Derived from a single-cell algal strain grown in enclosed ponds using proprietary methods, it features encapsulated high-DHA oil in a free-flowing powder format, prioritizing sustainability and reliability in feed formulations.

Jedwards International, Inc. provides Algae Oil with 40% DHA concentration, refined through distillation and incorporating tocopherol. This plant-based supplement addresses demand for non-marine omega-3 sources essential for human health and wellness.

ProCaps Laboratories, LLC's Algal DHA 250 delivers a highly concentrated, non-GMO algal oil formulation, developed as a sustainable plant-based DHA supplement responsive to consumer preferences for eco-friendly omega-3 options.

The algal DHA sector is advancing amid converging trends of health consciousness, sustainability imperatives, and regulatory support. Its positioning as a versatile, environmentally responsible ingredient across pharmaceuticals, nutraceuticals, food fortification, and beyond underscores potential for continued expansion, particularly in Europe, as production efficiencies improve and awareness of its multifaceted benefits proliferates.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Algal Docosahexaenoic Acid (DHA) Market Segmentation

  • By Application
  • Pharmaceuticals
  • Food and Beverage
  • Others
  • By Form
  • Oil
  • Powder
  • Softgel
  • By End User
  • Individuals
  • Industrial
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ALGAL DOCOSAHEXAENOIC ACID (DHA) MARKET BY APPLICATION

  • 5.1. Introduction
  • 5.2. Pharmaceuticals
  • 5.3. Food And Beverage
  • 5.4. Others

6. ALGAL DOCOSAHEXAENOIC ACID (DHA) MARKET BY FORM

  • 6.1. Introduction
  • 6.2. Oil
  • 6.3. Powder
  • 6.4. Softgel

7. ALGAL DOCOSAHEXAENOIC ACID (DHA) MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Individuals
  • 7.3. Industrial

8. ALGAL DOCOSAHEXAENOIC ACID (DHA) MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Corbion
  • 10.2. AlgiSys BioSciences Inc.
  • 10.3. Bioriginal Food & Science Corp
  • 10.4. ALGANEX GmbH
  • 10.5. childlifenutrition.com
  • 10.6. Apeiron Elementals
  • 10.7. LUS Health Ingredients BV
  • 10.8. Life's Code
  • 10.9. ProCaps Laboratories, LLC
  • 10.10. Jedwards International, Inc.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations